ClinicalTrials.Veeva

Menu

Risk Scoring Model for Endometrial Cancer (Cohort)

A

Ain Shams University

Status

Unknown

Conditions

Oncology

Treatments

Other: Scoring model

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

A prospective cohort study to assess RHEA ( recurrent vaginal bleeding, hypertension, endometrial thickness and age) scoring model for prediction of endometrial carcinoma

Enrollment

100 patients

Sex

Female

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All postmenopausalwomen with vaginal bleeding and endometrial thickness more than 4 mm

Exclusion criteria

  • all patients with vaginal bleeding arising from cervical or vaginal or vulval disease or due to hormonal replacement therapy (scheduled bleeding).

Trial design

100 participants in 1 patient group

Postmenopausal women
Treatment:
Other: Scoring model

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems